Klein Joseph III's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed May 5, 2026
- Accession no.
- 0000874015-26-000182
- Filed
- May 5, 2026
- Trade date
- May 1, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $743.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Klein Joseph IIICIK 0001206369 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | MOption exerciseAcquired | +10,111 | $47.11 | +$476,329.21 | 21,125 | Direct | |
| May 1, 2026 | Common Stock | SSaleDisposed | −8,680 | $73.35 | −$636,678 | 12,445 | Direct | |
| May 1, 2026 | Common Stock | SSaleDisposed | −1,431 | $74.45 | −$106,537.95 | 11,014 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | MOption exerciseDisposed | −10,111 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.